SEC Form 4 research
| Issuer | Contineum Therapeutics, Inc. |
|---|---|
| Tickers | CTNM |
| Reporting owners | 24 |
| Officers and directors | 3 |
| Last public filing | 2026-09-08 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-08 | 2026-09-08 | Stengone Carmine N. | S | 2,500 | $16.46 | Not reported |
| 2026-08-03 | 2026-08-03 | Stengone Carmine N. | S | 2,500 | $16.01 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.